Males | Females | p | |
---|---|---|---|
No. (%) | 224 (63) | 131 (37) | NA |
Age, yrs | 45.49 (13.36) | 44.88 (12.53) | NS |
Age of symptom onset, yrs | 25.73 (10.63) | 27.20 (10.43) | NS |
Disease duration, yrs | 19.78 (12.17) | 17.59 (12.86) | NS |
BASDAI | 3.75 (2.17) | 4.89 (2.28) | < 0.01 |
BASFI | 3.77 (2.63) | 4.59 (2.69) | < 0.01 |
BASMI | 4.26 (2.60) | 3.56 (2.24) | < 0.05 |
mSASSS | 26.97 (24.52) | 10.16 (14.85) | < 0.05 |
Therapy (%) | |||
NSAID | 182 (80.4) | 122 (92.6) | NA |
Corticosteroids | 43 (19) | 22 (16.5) | NA |
DMARD | 119 (52.6) | 67 (50.4) | NA |
Anti-TNF-α | 55 (24.2) | 27 (20.6) | NA |
AS: ankylosing spondylitis; BASDAI: Bath AS Disease Activity Index; BASFI: Bath AS Functional Index; BASMI: Bath AS Metrology Index; mSASSS: modified Stoke Ankylosing Spondylitis Spine Score; NSAID: nonsteroidal antiinflammatory drugs; DMARD: disease-modifying antirheumatic drugs; NA: not applicable; NS: not significant; TNF: tumor necrosis factor.